SCHEMBL17796494

SCHEMBL17796494

Cc1c(Cl)cncc1C(=O)N[C@@H]1CCOC1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CHRM4 P08173 1/20 0.46
▸ NPC1 O15118 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ HPGDS O60760 1/20 0.42
▸ P2RX7 Q99572 1/20 0.40
▸ PLAT P00750 1/20 0.40
▸ TGFBR1 P36897 1/20 0.40
▸ NAMPT P43490 2/20 0.40
▸ CNR2 P34972 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ MAPK8 P45983 1/20 0.38
▸ MAPK9 P45984 1/20 0.38
▸ MAPK10 P53779 1/20 0.38
▸ DGAT2 Q96PD7 4/20 0.38
▸ SMO Q99835 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ GABRA1 P14867 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13162036 0.78 NAMPT (0.50) NPC1RAB9AHPGDSTGFBR1NAMPT
SCHEMBL13162009 0.78 NAMPT (0.50) NPC1RAB9AHPGDSTGFBR1NAMPT
SCHEMBL17796380 0.76 EGLN1 (0.49) CHRM4NPC1RAB9AHPGDSPLAT
SCHEMBL17796768 0.76 EGLN1 (0.49) CHRM4NPC1RAB9AHPGDSPLAT
SCHEMBL29062256 0.72 TAS1R3 (0.54) CHRM4NPC1RAB9AHPGDSP2RX7
SCHEMBL13634628 0.71 NPC1 (0.64) NPC1RAB9ANAMPT
SCHEMBL13162643 0.71 NPC1 (0.64) NPC1RAB9ANAMPT
SCHEMBL27962651 0.71 NAMPT (0.50) HPGDSNAMPTDGAT2CYP2C9CYP2C19
SCHEMBL19877022 0.71 NAMPT (0.50) HPGDSNAMPTDGAT2CYP2C9CYP2C19
SCHEMBL7456523 0.70 NAMPT (0.50) CHRM4HPGDSPLATTGFBR1NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3029031-A1 HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2016-06-08 — — EP disclosed
Send feedback